Sensitivity to ageing of the limbic dopaminergic system: A review

Mechanisms of Ageing and Development

Volumn 106, Issue 1-2, 1998, Pages 57-92

  Barili, Paolo ^a,b   De Carolis, Gionni ^a   Zaccheo, Damiano ^c   Amenta, Francesco ^a,d  

^a UNIVERSITY OF CAMERINO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Dipto Sci Farmacologiche Med S   (Italy)

Author keywords

Ageing; Dopamine; Innervation; Limbic system; Receptors; Senile dementia

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOLAMINE; DOPAMINE; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; NORADRENALIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; COGNITION; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; EMOTION; HUMAN; LIMBIC SYSTEM; MESENCEPHALON; MONKEY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RAT; REVIEW; RODENT; SENILE DEMENTIA; VENTRAL TEGMENTUM;

ANIMALIA; RODENTIA;

EID: 0032403206     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00104-3     Document Type: Article

References (248)

1. Adolfsson, R., Gottfries, C.G., Roos, E., Winblad, B., 1979. Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age and a review of the literature. J. Neural Transm. 45, 81-105.
2. Adolfsson, R., Gottfries, G.G., Oreland, L., Wyberg, A., Winblad, B., 1980. Increased activity of brain and platelet manoamine oxidase in dementia of Alzheimer type. Life Sci. 27, 1029-1034.
3. Alexopoulos, G.S., Libernan, K.W., Young, R.C., 1984. Platelet MAO activity in primary degenerative dementia. Am. J. Psychiatry 141, 97-99.
4. 3H]GBR-12935 in Alzheimer's disease. Eur. Neurol. 30, 181-185.
5. Amenta, F., Cavallotti, C., De Michele, M., Ricci, A., Vega, J.A., 1990a. Changes of dopamine-sensitive cyclic AMP-generating system in the rat hippocampus as a function of age. Arch. Gerontol. Geriatr. 10, 279-285.
6. Amenta, F., Cavallotti, G., Collier, W.L., De Michele, M., Ricci, A., 1990b. Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex. Mech. Ageing Dev. 54, 63-73.
7. Amenta, F., Zaccheo, D., Collier, W.D., 1991. Neurotransmitters, neuroreceptors and aging. Mech Ageing Dev. 61, 249-273.
8. Arai, H., Kosaka, K., lizuka, T., 1984. Ghanges of biogenic amines and their metabolises in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43, 388-393.
9. Araki, T., Kato, H., Shuto, K., Fujiwara, T., Itoyama, Y., 1997. Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography. J. Neurol. Sci. 148, 131-137.
10. 1B receptor in central nervous system using anti-receptor antisera. Brain Res. 746, 141-150.
11. 3 subtypes. Brain Res. 649, 95-110.
12. Arnold, S.E., Hyman, B.T., Flory, J., Damasio, A.R., Van Hoesen, G.W., 1991. The topographical and neuroanatomiml distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116.
13. 1 receptor mechanism in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116, 143-151.
14. 2 receptor mechanism contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J. Neurosci. 15, 3429-3439.
15. Arriagada, P.V., Growdon, J.H., Hedly-Whyte, E.T., Hyman, B.T., 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
16. Bachevalier, J., Landis, L.C., Walker, L.G., Brickson, M., Mishkin, M., Price, D.L., Cork, L.C., 1991. Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction. Neurobiol. Aging 12, 99-111.
17. Bannon, M.J., Roth, R.H., 1983. Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35, 53-68.
18. Bartus, R.T., 1979. Effects of aging on visual memory, sensory processing and discrimination learning in a nonhuman primate. In: Ordy, J.M., Brizee, K. (Eds.), Sensory Systems and Communication in the Elderly, Aging Vol. 10. Raven Press, New York, pp. 85-114.
19. Bartus, R.T., Fleming, D., Johnson, H.R., 1978. Aging in the rhesus monkey: debilitating effects on short-term memory. J. Gerontol. 33, 858-871.
20. Bartus, R.T., Dean, R.L., Fleming, D.L., 1979. Aging in the rhesus monkeys: effects on visual discrimination learning and reversal learning. J. Gerontol. 34, 209-219.
21. Bauer, R.H., Fuster, J.M., 1978. Effects of D-amphetamine and prefrontal cortical cooling on delayed matching-to-sample behavior. Pharmacol. Biochem. Behav. 8, 243-249.
22. Bayles, K.A., Tomoeda, C.K., Wood, J.A., Montgomery, E.B. Jr., Cruz, R.F., Azuma, T., McGeagh, A., 1996. Change in cognitive function in idiopathic Parkinson's disease. Arch. Neurol. 53, 1140-1146.
23. Bebbington, P., Wilkins, S., Jones, P., Foerster, A., Murray, R., Toone, B., Lewis, S., 1993. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br. J. Psychiatry 162, 72-79.
24. Ben-Shachar, D., Zuk, R., Glinka, Y., 1995. Dopamine neurotoxicity: inhibition of mitochondria respiration. J. Neurochem. 64, 718-723.
25. Berendse, H.W., Galis-De Graaf, Y., Groenewegen, H.J., 1992. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. Comp. Neurol. 316, 314-347.
26. Berger, B., Tassin, J.P., Blanc, G., Moyne, M.A., Thierry, A.M., 1974. Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Res. 81, 332-337.
27. Berger, B., Trottier, S., Verney, C., Gaspar, P., Alvarez, C., 1988. Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: a radioautographic study. J. Comp. Neurol. 273, 99-119.
28. 5 dopamine receptors in primate brain. J. Neurosci. 15, 7821-7836.
29. Berman, K.F., Weinberger, D.R., 1990. The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. Progr. Brain Res. 85, 521-536.
30. 2 receptor mRNA. Brain Res. 564, 203-219.
31. 2 subtypes of dopamine receptors in the rat brain. J. Neurosci. 6, 3177-3188.
32. Bradley, V.A., Welch, J.L., Dick, D.J., 1989. Visuospatial working memory in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 52, 1228-1235.
33. 2 receptor mRNA with non-radioactive in situ hybridization histochemistry. Neurosci. Lett. 142, 223-227.
34. Brown, F.W., 1993. The neurobiology of late-life psychosis. Crit. Rev. Neurobiol. 7, 275-289.
35. Brown, R.G., Marsden, C.D., 1987. Neuropsychology and cognitive function in Parkinson's disease: an overview. In: Marsden, C.D., Fahn, S. (Eds.), Movement Disorders, Vol. 2. Butterworths, London, pp. 99-123.
36. Brown, R.M., Crane, A.M., Goldman-Rakic, P.S., 1979. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res. 168, 133-150.
37. Brozoski, T., Brown, R.M., Rosvold, H.E., Goldman-Rakic, P.S., 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 205, 929-931.
38. Buchsbaum, M.S., Ingvar, D.H., Kessler, R., Waters, R.N., Cappelletti, J., van Kammen, D.P., King, A.C., Johnson, J.L., Manning, R.G., Flynn, R.W., Mann, L.S., Bunney, W.E. Jr., Sokoloff, L., 1982. Cerebral glucography with positron tomography: use in normal subjects and in patients with schizophrenia. Arch. Gen. Psychiatry 39, 251-259.
39. 2 receptors in the brain of several mammalian species. J. Neural. Transm. [GenSect] 80, 105-127.
40. Carlsson, A., Winblad, B., 1976. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytiramine levels in human basal ganglia. J. Neural Transm. 38, 271-301.
41. Carlsson, A., Adolfsson, R., Aquilonius, S.-M., Gottfries, C.-G., Oreland, L., Svennerholm, L, Winblad, B., 1980. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. In: Goldstein, M. (Ed.), Ergot compounds and brain function: neuroendocrine and neuropsychiatric aspects. New York, Raven Press, pp. 295-304.
42. 4 receptor gene in psychotic patients. Biol. Psychiatry 34, 459-464.
43. 3H]mazindol. Neuroscience 49, 317-327.
44. Coleman, P.D., Rogers, K.E., Flood, D.G, 1990. Neuronal plasticity in normal aging and deficient plasticity in Alzheimer's disease: a proposed intercellular signal cascade. In: Coleman, P., Higgins, G., Phelps, C. (Eds.), Progress in Brain Research, Vol. 86. Elsevier, Amsterdam, pp. 75-87.
45. Cooper, S.J., 1991. Interactions between endogenous opioids and dopamine: implications for reward and aversion. In: Wilner, P., Scheel-Kruger, J. (Eds.), The mesolimbic dopamine system: from motivation to action. New York, Wiley, pp. 331-366.
46. 1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type. Brain Res. 475, 164-167.
47. 2 sites in Parkinson syndrome of different etiology. Brain Res. 483, 30-38.
48. 1 sites. Neuroscience 28, 263-273.
49. Damask, S.P., Bovenkerk, K.A., de la Pena, G., Hoversten, K.M., Peters, D.B., Valentine, A.M., Meador-Woodruff, J.H., 1996. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Mol. Brain Res. 41, 241-249.
50. Daniel, D.G., Weinberger, D.R., Jones, D.W., Zigun, J.R., Coppola, R., Handel, S., Bigelow, L.B., Goldberg, T.E., Berman, K.F., Kleinman, J.E., 1991. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11, 1907-1917.
51. Davis, K.L., Kahn, R.S., Ko, G., Davidson, M., 1991. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 1474-1486.
52. Dawson, T.M., Gehlert, D.R., McCabe, R.T., Barnett, A., Wamsley, J.K., 1986. D1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J. Neurosci. 6, 2352-2365.
53. De Jong, R.N., Pope, A., 1975. Complex cerebral functions. In: Tower, D.B., Chase, T.N. (Eds.), The Nervous System, Clinical Neurosciences, Vol. 2. Raven Press, New York, pp. 449-456.
54. 1 dopamine receptors in human frontal cortex. Brain Res. 528, 308-310.
55. 4 dopamine receptor in rat brain. Neurochem. Res. 22, 401-407.
56. 4 dopamine receptor in rat brain with sequence specific antibodies. Mol. Brain Res. 45, 1-12.
57. 2 receptor mRNA in brain areas of two rat strains. Brain Res. Mol. Brain Res. 12, 357-359.
58. Deutch, A.Y., 1993. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. Neural. Transm. Gen. Sect. 91, 197-221.
59. Di Chiara, G., Imperato, A., 1988. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic systems of freely moving rats. Proc. Natl Acad. Sci. U.S.A. 85, 5274-5278.
60. Di Chiara, G., Morelli, M., Acquas, E., Carboni, E., 1992. Functions of dopamine in the extrapyramidal and limbic systems. Arzneim. Forsch./Drug Res. 42, 231-237.
61. Dubois, B., Pillon, B., Lhermitte, F., Agid, Y., 1990. Cholinergic deficiency and frontal lobe dysfunction in Parkinson's disease. Ann. Neurol. 28, 117-121.
62. Dymecki, J., Lechowicz, W., Bertrand, E., Szpak, G.M., 1996. Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson's disease. Folia Neuropathol. 34, 102-106.
63. El Awar, M., Becker, J.T., Hammond, K.M., Nebes, R.D., Boller, F., 1987. Leaming deficits in Parkinson's disease: comparison with Alzheimer's disease and normal aging. Arch. Neurol. 44, 180-184.
64. 11C-raclopride. Psychopharmacology 92, 278-284.
65. Farkas, T., Wolf, A.P., Jaeger, J., Brodie, J.D., Christman, D.R., Fowler, J.S., 1984. Regional brain glucose metabolism in chronic schizophrenia: a positron emission transaxial tomographic study. Arch. Gen. Psychiatry 41, 293-300.
66. Ferino, F., Thierry, A.M., Glowinski, J., 1987. Anatomical and electrophysiological evidence for a direct projection from Ammon's hom to the medial prefrontal cortex in the rat. Exp. Brain Res. 65, 421-426.
67. Ferron, A., Thierry, A.M., Saffroy, M., Glowinski, I., 1984. Inhibitory influence of the mesocortical dopaminergic system on the spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res. 302, 257-265.
68. Fibiger, H.C., Phillips, A.G., 1986. Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In: Mountcastle, V.B., Bloom, F.E., Geiger, S.R. (Eds.), Handbook of physiology. The nervous system, Vol. 11. American Psychological Society, Bethesda, MD, pp. 647-675.
69. Fisher, P., Gatterer, G., Symanyi, M., Jellinger, K., Marterer, A., Danielczyk, K., Danielczyk, W., 1990. Memory deficits in advanced Parkinson's disease. J. Neural. Transm. 2, 59-70.
70. Flynn, D.D., Weinstein, D.A., Mash, D.C., 1991. Loss of high affinity binding to M1 muscarinic receptors in Alzheimer's disease. Implication for the failure of cholinergic replacement therapies. Ann. Neurol. 19, 256-261.
71. Fornstedt, B., 1990. Role of catechol autooxidation in the degeneration of dopamine neurons. Acta Neuropl. Scand. (Suppl.) 129, 12-14.
72. Fowler, C.J., Wiber, A., Oreland, L., Marcusson, J., Winblad, B., 1980. The effect of age on the activity and molecular properties of human brain. J. Neural. Transm. 49, 1-20.
73. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl Acad. Sci. U.S.A. 88, 3772-3776.
74. Friedman, H.R., Goldman-Rakic, P.S., 1988. Activation of the hippocampus and dentate gyrus by working memory: a 2-deoxyglucose study of behaving rhesus monkeys. J. Neurosci. 8, 4693-4706.
75. Fuster, J.M., 1989. The Prefrontal Cortex: anatomy, physiology and neurophysiology of the frontal lobe. New York, Raven Press.
76. Fuster, J.M., 1991. The prefrontal cortex and its relation to behavior. Progr. Brain Res. 87, 201-211.
77. Fuxe, K., Agnati, L.F., Kalia, M., Goldstein, M., Andersson, K., Harfstrand, A., 1985. Dopaminergic systems in the brain and pituitary. In: Fluckiger, E., Muller, E.E., Thorner, M.O. (Eds.), Basic and clinical aspects of neuroscience: the dopaminergic system. Springer-Verlag, Berlin, pp. 11-25.
78. Gallagher, M., Burwell, R.D., 1989. Relationship of age-related decline across several behavioral domains. Neurobiol. Aging 10, 691-708.
79. Gallagher, M., Burwell, R.D., Kodsi, M.H., McKinney, M., Southerland, S., VellaRountree, L., Lewis, M.H., 1990. Markers for biogenic amines in the aged rat brain: relationship to decline in spatial learning ability. Neurobiol. Aging 11, 507-514.
80. Gasbarri, A., Packard, M.G., Campana, E., Pasitti, C., 1994. Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation. Brain Res. Bull. 33, 445-452.
81. 2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7, 1050-1063.
82. Gedye, A., 1991. Tourette syndrome attributed to frontal lobe dysfunction: numerous etiologies involved. J. Clin. Psycol. 47, 233-252.
83. 3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res. 681, 1-7.
84. Gingrich, J.A., Caron, M.G., 1993. Recent advances in the molecular biology of dopamine receptors. Ann. Rev. Neurosci. 16, 299-321.
85. 1 dopamine receptor. Neurochem. Int. [Suppl.] 20, 9S-15S.
86. Godbout, R., Mantz, J., Pirot, S., Glowinski, J., Thierry, A.M., 1991. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological localization. J. Pharm. Exp. Ther. 258, 728-738.
87. Godefroy, F., Bassant, M.H., Weil-Fugaza, J., Lamour, Y., 1989. Age-related changes in dopaminergic and serotonergic indices in the rat forebrain. Neurobiol. Aging 10, 187-190.
88. Godefroy, F., Bassant, M.H., Lamour, Y., Weil-Fugaza, J., 1991. Effect of aging on dopamine metabolism in the rat cerebral cortex: a regional analysis. J. Neural. Transm. [Gen. Sect.] 83, 13-24.
89. Goldman, P.S., Rosvold, H.E., 1970. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp. Neurol. 27, 291-304.
90. Goldman-Rakic, P.S., Brown, R.M., 1981. Regional change of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6, 177-187.
91. Goldman-Rakic, P.S., Lidow, M.S., Gallager, D.W., 1990. Overlap of dopaminergic, adrenergic, and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10, 2125-2138.
92. 2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4, 354-373.
93. Goldstein, L.E., Rasmusson, A.M., Bunney, B.S., Roth, R.H., 1994. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat. J. Neurosci. 14, 4937-4950.
94. Goldstein, M., Deutch, A.Y., 1992. Dopaminergic mechanism in the pathogenesis of schizophrenia. FASEB J. 6, 2413-2421.
95. Gotham, A.M., Brown, R.G., Marsden, C.D., 1988. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off levodopa. Brain 111, 299-321.
96. Gottfries, C.G., 1979. Amine metabolism in normal ageing and in dementia disorders. In: Roberts, P.J. (Ed.), Biochemistry of dementia. Wiley, Chichester, pp. 213-234.
97. Gottfries, C.G., Adolfsson, R., Aquilonius, S.-M., Carlsson, A., Oreland, L., Svennerholm, L., Winblad, B., 1980. Parkinsonism and dementia disorders of the Alzheimer type: similarities and differences. In: Rhinne, U.K., Kingler, M., Stamm, G. (Eds.), Parkinson's disease - Current progress, problems and management. Elsevier/North-Holland Biomedical Press, Amsterdam, pp. 197-208.
98. Gottfries, C.G., Adolfsson, R., Aquilonius, S.M., Carlsson, A., Eckernas, S.A., Nordberg, L., Oreland, L., Svennerholm, L., Wyberg, A., Winblad, B., 1983. Biochemical changes in dementia disorders of Alzheimer type (AS/SDAT). Neurobiol. Aging 4, 261-271.
99. Goudsmit, E., Feenstra, M.G.P., Swaab, D.F., 1990. Central monoamine metabolism in the male Brown-Norway rat in relation to aging and testosterone. Brain Res. Bull. 25, 755-763.
100. Graham, D.G., 1984. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5, 83-96.
101. Hagan, J.J., Middlemiss, D.N., Sharpe, P.C., Poste, G.H., 1997. Parkinson's disease: prospects for improved drug therapy. Trends Pharmacol. Sci. 18, 156-163.
102. Hallywell, B., 1992. Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
103. Harik, S.I., McCracken, K.A., 1986. Age related increase in presynaptic noradrenergic markers of the rat cerebral cortex. Brain Res. 381, 125-130.
104. Heindl, W.C., Salmon, D.P., Shults, C.W., Walicke, P.A., Butters, N., 1989. Neuropsychological evidence for multiple incipit memory systems: a comparison of Alzheimer's, Huntington's and Parkinson's disease. J. Neurosci. 9, 582-587.
105. 3H]7-hydroxyN,N-di-n-propyl-2-aminotetralin. Brain Res. 648, 222-228.
106. 1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69, 1067-1074.
107. 1-like receptors in the hippocampal formation of rat, monkey and human brains. Neuroscience-Net 1, Article # 10005 (Internet).
108. 3H]GBR-125 binding site density in the prefrontal cortex of controls and schizophrenic. Biol. Psychiatry 37, 175-182.
109. Hoehn, M.M., Yahr, M.D., 1967. Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
110. 1 dopamine receptor in rat brain reveals its axonal transport, pre-and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl Acad. Sci. U.S.A. 89, 11988-11992.
111. Huang, R.-L., Wang, C.-T., Tai, M.-Y., Tsai, Y.-F., Peng, M.-T., 1995. Effects of age on dopamine release in the nucleus accumbens and amphetamine-induced locomotor activity in rats. Neurosci. Lett. 200, 61-64.
112. Hurley, M.J., Stubbs, C.M., Jenner, P., Marsden, C.D., 1996. D3 receptor expression within the basal ganglia is not affected by Parkinson's disease. Neurosci. Lett. 214, 75-78.
113. Ishikawa, K., Ott, T., McGaugh, J.L., 1982. Evidence for dopamine as a transmitter in dorsal hippocampus. Brain Res. 232, 222-226.
114. Iversen, L.L., Rossor, M.N., Reynolds, G.P., Hills, R., Roth, M., Mountjoy, C.Q., Foote, J.H., Morrison, J.H., Bloom, F.E., 1984. Loss of dopamine-β -hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer type. Neurosci. Lett. 39, 95-100.
115. 3H]mazindol autoradiography. J. Neurosci. 36, 1513-1521.
116. Javoy-Agid, F., Agid, Y., 1980. Is the mesocortical system involved in Parkinson's disease? Neurology 30, 1326-1330.
117. Jay, T.M., Glowinski, J., Thierry, A.M., 1995. Inhibition of hippocampo-prefrontal cortex excitatory responses by the mesocortical DA systems. Neuroreport 6, 1845-1848.
118. Joseph, J., Roth, G.S. 1983. Age-related alterations in dopaminergic mechanism. In: Samuel, D., Algeri, S., Gershon, S., Grimm, V., Toffano, G. (Eds.), Aging of the brain. Raven Press, New York, pp. 245-256.
119. Joyce, J.N., 1993. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology 112, S16-S34.
120. 2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci. Lett. 154, 171-174.
121. Kebabian, J.W., Calne, D.B., 1979. Multiple receptors for dopamine. Nature 277, 93-96.
122. Kish, S.J., Shannak, K., Rajput, A., Deck, J.H.N., Hornykiewicz, O., 1992. Aging produces a specific pattern of striatal dopamine loss - implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58, 642-648.
123. 125I-NCQ 298. Neurosci. Lett. 125, 12-14.
124. 125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 611-617.
125. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5, 145-153.
126. Laroche, S., Jay, T.M., Thierry, A.M., 1990. Long-term potentation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region. Neurosci. Lett. 114, 184-190.
127. Laurier, L.G., O'Dowd, B.F., George, S.R., 1994. Heterogeneous tissue-specific transcription of dopamine receptor subtypes messenger RNA in rat brain. Mol. Brain Res. 25, 344-350.
128. Law-Tho, D., Hirsch, J., Crepel, F., 1994. Dopamine modulation of synaptic transmission in rat prefrontal cortex. An in vitro electrophysiological study. Neurosci. Res. 21, 151-160.
129. Le Moal, M., Stinus, L., Galey, D., 1976. Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp. Neurol. 50, 521-535.
130. 3 autoreceptors inhibits firing of ventral segmental dopaminergic neurones in vivo. Eur. J. Pharmacol. 275, R7-R9.
131. 2-like dopamine receptors in the rat brain. J. Pharmacol. Exp. Ther. 262, 929-935.
132. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl Acad. Sci U.S.A. 89, 8155-8159.
133. Levin, E.D., McGurk, S.R., Rose, J.E., Butcher, L.L., 1990. Cholinergic-dopaminergic interaction in cognitive performance. Behav. Neural Biol. 54, 271-299.
134. 3H]lraclopride. Proc. Natl Acad. Sci U.S.A. 86, 6412-6416.
135. Lindvall, O., Björklund, A., 1984. General organization of cortical monoamine systems. In: Descarries, L., Reader, J.N.H. (Eds), Monoamine innervation of the cerebral cortex. Alan R. Liss, New York, pp. 9-40.
136. Lohr, J.B., Bracha, H.S., 1988. Association of psychosis and movement disorders in the elderly. Psychiatr. Clin. North Am. 11, 61-81.
137. Loopuijt, L.D., Sebens, J.B., 1990. Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer's disease. Brain Res. 529, 239-244.
138. Luine, V., Bowling, D., Hearns, M., 1990. Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res. 537, 271-278.
139. Mahut, H., Zola-Morgan, S., Moss, M., 1982. Hippocampal resections impair associative learning and recognition memory in the monkey. J. Neurosci. 2, 1214-1229.
140. Martilla, R.J., Rinne, U.K., 1976. Dementia in Parkinson's disease. Acta Neurol. Scandal 54, 431-441.
141. 4 receptor in human cerebral cortex and striatum. J. Neurochem. 66, 915-919.
142. McEntee, W.J., Crook, T.H., 1990. Age-associated memory impairment. Neurology 40, 526-530.
143. McGeer, E.G., 1981. Neurotransmitter systems in aging and senile dementia. Progr. Neuropsychopharmacol. 5, 435-445.
144. McGurk, S.R., Levin, E.D., Butcher, L.L., 1988. Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav. Neural Biol. 49, 234-239.
145. 2 antagonists. Psychopharmacology 99, 371-373.
146. 5 dopamine receptor mRNA in rat brain. Neurosci. Lett. 145, 209-212.
147. Meador-Woodruff, J.H., Grandy, D.K., Van Tol, H.H.M., Damask, S.P., Little, K.Y., Watson, S.J. Jr., 1994. Dopamine receptor gene expression in the human medial temporale lobe. Neuropsychopharmacology 10, 239-248.
148. Meador-Woodruff, J.H., Damask, S.P., Wang, J., Haroutunian, V., Davis, K.L., Watson, S.J., 1996. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15, 17-29.
149. Mellers, J.D., Quinn, N.P., Ron, M.A., 1995. Psychotic and depressive symptoms in Parkinson's disease. A study of the growth hormone response to apomorphine. Br. J. Psychiatry 167, 522-526.
150. 3 receptor mRNA in human and rat brain. Neurochem. Int. 20 (suppl.), 335-435.
151. 2 receptors. Neuroscience 36, 403-410.
152. Morgan, D., Finch, C., 1988. Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals. Ann. New York Acad. Sci. 515, 213-228.
153. Murphy, B.L., Arnsten, A.T.F., Goldman-Rakic, P.S., Roth, R.H., 1996. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl Acad. Sci. U.S.A. 93, 1325-1329.
154. 2 receptors to mesostriatal regions of human forebrain. Proc. Natl Acad. Sci. U.S.A. 91, 11271-11275.
155. 1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats. Life Sci. 55, 1585-1593.
156. Nagatsu, T., 1978. Metabolism and catecholamines. Metab. Dis. 15, 15-26.
157. Nalepa, I., Pintor, A., Fortuna, S., Vetulani, J., Michalek, A., 1989. Increased responsiveness of the cortical phosphatidylinositol system to noradrenaline in senescenta rats. Neurosci. Lett. 107, 195-199.
158. Nazarali, A.J., Reynolds, G.P., 1992. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol. Neurobiol. 12, 581-587.
159. 3 receptor antisense influences dopamine synthesis in rat brain. Neuroreport 6, 573-576.
160. Niznik, H.B., Van Tol, H.H.M., 1992. Dopamine receptor genes: new tools for molecular psychiatry. J. Psychiat. Neurosci. 17, 158-178.
161. 4 receptor sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 4, 137-146.
162. Owen, A.M., James, M., Leigh, P.N., Summers, B.A., Marsden, C.D., Quinn, N.P., Lange, K.W., Robbins, T.W., 1992. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115, 1727-1751.
163. Palmer, A.M., Wilcock, G.K., Esiri, M.M., Francis, P.T., Bowen, D.M., 1987. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res. 401, 21-238.
164. Parent, A., Rowe, W., Meaney, M.J., Quirion, R., 1995. Alterations in the production of inositol phosphates and diacylglicerol in aged memory-impaired rats following stimulation of muscarinic, metabotrophic-glutamate and endothelin receptors. J. Pharmacol. Exp. Ther. 272, 1110-1116.
165. 2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fisher 344 rats. J. Pharmacol. Exp. Ther. 254, 539-545.
166. Park, S., Holzman, P.S., 1992. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry 49, 975-982.
167. Pearce, B.R., Palmer, A.M., Bowen, D.M., Wilcock, G.K., Esiri, M.M., Davidson, A.N., 1984. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Neurochem. Pathol. 2, 221-232.
168. Pearce, J., 1974. Mental changes in Parkinsonism. Br. Med. J. 2, 445.
169. Pirizzolo, F.J., Hansch, E.C., Mortimer, J.A., Webster, D.D., Kuskowski, M.A., 1982. Dementia in Parkinson's disease: a neuropsychological analysis. Brain Cogn. 1, 71-83.
170. 3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers. Neuroscience 20, 157-168.
171. Porras, A., Sanz, B., Mora, F., 1997. Dopamine-glutamate interactions in the prefrontal cortex of the conscious rat: studies on ageing. Mech. Ageing. Dev. 99, 9-17.
172. 3H]NGD 94-1. J. Pharmacol. Exp. Ther. 282, 1020-1027.
173. Raoul, P., Lieury, A., Decombe, R., Chauvel, P., Allain, H., 1992. Deficit mnesique au cors de la maladie de Parkinson. Vieillessement accelere des processus de rappel. Presse Med. 21, 69-73.
174. Rapp, P.R., Amaral, D.G., 1989. Evidence for task-dependent memory dysfunction in the aged monkey. J. Neurosci. 9, 3568-3576.
175. 1 receptors in cerebral cortex and neostriatum: evidence for heterogeineities in affinity states and cortical distribution. J. Neurochem. 50, 451-463.
176. Reinikainen, K.J., Paljarvi, L., Halonen, T., Malminen, O., Kosma, V.M., Laakso, M.P., Riekkinen, P.J., 1988. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol. Aging 9, 245-252.
177. Reinikainen, K.J., Soininen, H., Riekkinen, P.J., 1990. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res. 27, 576-586.
178. 2 dopamine receptors in the inhibition of the evoked release of H3 GABA in the rat prefrontal cortex. Neuroscience 43, 323-330.
179. 3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay. Mol. Brain Res. 33, 97-103.
180. 3 receptor antagonist, (+)-S 14297. Eur. J. Pharmacol. 265, 175-177.
181. Rosene, D.L., Van Hoesen, G.W., 1987. The hippocampal formation of the primate brain. In: Jones, E.G., Peters, A. (Eds.), Cerebral cortex, Vol. 6. Plenum, New York, pp. 361-370.
182. Rossor, M.N., 1982. Dementia. Lancet 2, 1200-1204.
183. Roth, G.S., Joseph, J., 1988. Peculiarities of the effect of hormonal transmitters during aging: modulation of changes in dopaminergic action. Gerontology 34, 22-28.
184. Roth, R.H., 1984. CNS dopamine autoreceptors: distribution, pharmacology and function. Ann. New York Acad. Sci. 430, 27-42.
185. Ruzicka, E., Roth, J., Spackova, N., Mecir, P., Jech, R., 1994. Apomorphine induced cognitive changes in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 57, 998-1001.
186. 2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J. Comp. Neurol. 348, 94-110.
187. Salamone, J.D., 1992. Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacologia 107, 160-174.
188. Santiago, M., Machado, A., Reinoso.Suarez, F., Cano, J., 1988. Changes in biogenic amines in rat hippocampus during development and aging. Life Sci. 42, 2503-2508.
189. Sawaguchi, T., Goldman-Rakic, P.S., 1991. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251, 947-950.
190. Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., Agid, Y., 1983. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolises in Parkinson's Disease. Brain Res. 275, 321-328.
191. Schneider, L.S., Severson, J.A., Chiu, H., Pollock, V.E., Sloane, R.B., Frederickson, E.R., 1988. Platelet tritiated imipramine binding and MAO activity in Alzheimer's patients with agitation and delusion. Psychiatry Res. 25, 311-322.
192. Schwartz, J.M., 1997. Obsessive-compulsive disorder. Sci. Med. 1996, 14-23.
193. Seeman, P., 1987. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152.
194. Seeman, P., Lee, T., Chau-Wong, M., Wong, K., 1976. Antipsychotic drug doses and neurolepticidopamine receptors. Nature 261, 717-719.
195. Seitelberger, F., 1992. Aging and cognition. Neurobiological and neuropsychological aspects. Evol. Cogn. 2, 135-150.
196. Sen, A.K., Lee, T., 1988a. Receptors and Ligands in Neurology. Cambridge University Press, Cambridge.
197. Sen, A.K., Lee, T., 1988b. Receptors and Ligands in Psychiatry. Cambridge University Press, Cambridge.
198. Sesack, S.R., Bunney, B.S., 1989. Pharmacological characterization of the receptor mediating electrophysiological response to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. J. Pharmacol. Exp. Ther. 248, 1323-1333.
199. Shippenberg, T.S., Herz, A., Spanagel, R., Bals-Kubik, R., 1991. Neural substrates mediating the motivational effects of opioids. In: Racagni, G., Brunello, N., Fukuda, T. (Eds.), Biological Psychiatry. Elsevier, Amsterdam, pp. 33-35.
200. Shue, K.L., Douglas, V.l., 1992. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn. 20, 104-124.
201. Sibley, D.R., Monsma, F.J. Jr., 1992. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13, 61-69.
202. 3 receptors on learning and memory in the rat. Eur. J. Pharmacol. 336, 107-112.
203. Simon, H., Scatton, B., Le Moal, M., 1980. Dopaminergic A10 neurones are involved in cognitive functions. Science 286, 150-151.
204. Smiley, J.F., Levey, A.I., Ciliax, B.J., Goldman-Rakic, P.S., 1994. D1 dopamine receptors immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl Acad. Sci. U.S.A. 91, 5720-5724.
205. Sokoloff, P., Schwartz, J.-C., 1995. Novel dopamine receptors half a decade latter. Trends Pharmacol. Sci. 16, 270-275.
206. Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.L., Schwartz, J.C., 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target of neuroleptics. Nature 347, 146-151.
207. Spina, M.B., Choen, G., 1989. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl Acad. Sci U.S.A. 86, 1398-1400.
208. 2 receptor mRNA in rat brain. Eur. J. Pharmacol. 225, 143-150.
209. Stam, C.J., Visser, S.L., Op de Coul, A.A., De Sonneville, L.M., Schellens, R.L., Brunia, C.H., de Smet, J.S., Gielen, G., 1993. Disturbed frontal regulation of attention in Parkinson's disease. Brain 116, 1139-1158.
210. Stenström, A., Hardy, J., Oreland, L., 1987. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. Biochem. Pharmacol. 36, 2931-2935.
211. Stern, M.B., Gur, R.C., Saykin, A.J., Hurtig, H.I., 1986. Dementia of Parkinson's disease and Alzheimer's disease. J. Am. Geriatr. Soc. 34, 475-478.
212. Stern, Y., Mayeux, R., 1986. Intellectual impairments in Parkinson's disease. Adv. Neurol. 45, 405-407.
213. Stern, Y., Richards, M., Sano, M., Mayeux, R., 1993. Comparison of cognitive changes in patients of Alzheimer's disease and Parkinson's disease. Arch. Neurol. 44, 1040-1045.
214. Storga, D., Vrecko, K., Birkmayer, J.G.D., Reibnegger, G., 1996. Monoaminergic neurotransmitters, their precursor and metabolises in brains of Alzheimer patients. Neurosci. Lett. 203, 29-32.
215. Strange, P.G., 1993. Dopamine receptors: structure and function. Progr. Brain Res. 99, 167-179.
216. Streker, E.M., Zigmond, M.J., 1986. Brain monoamines, homeostasis, and adaptive behavior. In: Bloom, F.E., Geiger, S., Mountcastle, S.R. (Eds.), Handbook of Physiology. The Nervous System, Vol. 4. American Psychological Society, Bethesda, MD, pp. 677-700.
217. Strolin-Benedetti, M., Keane, P.E., 1980. Differential changes in monoamine oxidase A and B activity in the aging rat brain. J. Neurochem. 355, 1026-1032.
218. 1 dopamine receptors measured by positron emission tomography. Psychopharmacology 103, 41-45.
219. Taghzouti, K., Le Moal, M., Simon, H., 1986. Dopaminergic innervation of the lateral septum and learning processes. Neurosci. Lett., Suppl. 26, S332.
220. Tandon, P., Mundy, W.R., Ali, S.F., Nanry, K., Rogers, B.C., Tilson, H.A., 1991. Agedependent changes in receptor stimulated phosphoinositide turnover in the rat hippocampus. Pharmac. Biochem. Behav. 38, 861-867.
221. Taylor, A., Saint-Cyr, J.A., Lang, A.E., 1985. Dementia prevalence in Parkinson's disease. Lancet 1, 1037.
222. 11C]nomifensine and positron emission tomography: the effects age and Parkinson's disease. Acta Neurol. Scand. 77, 192-201.
223. Thierry, A.M., Le Douarin, C., Penit, J., Ferron, A., Glowinski, J., 1986. Variation in the ability of neuroleptics to block the inibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex. Brain Res. Bull. 16, 155-160.
224. Toide, K., 1989. Effects of anti-dementia drug hopantenate calcium upon striatal dopaminergic neurons in young and aged rats. Arch. Int. Pharmacodyn. 299, 7-13.
225. Tomlinson, B.E., Corsellis, J.A.N., 1984. Ageing and the dementias. In: Adams, J.H., Corsellis, J. A.N., Duchen, L.W. (Eds.), Greenfield's Neuropathology. Wiley, New York, pp. 951-1025.
226. Torack, R.M., Morris, J.C., 1992. Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease. J. Neural Transm. Parkinson's Dis. Dementia Sect. 4, 165-171.
227. 4 receptor mRNA levels in rat brain and pituitary during aging. Neurobiol. Aging 15, 713-719.
228. 4 receptor with high affinity for antipsychotic dozapine. Nature 350, 610-614.
229. Walker, L.C., Kitt, C.A., Struble, R.G., Wagster, M.V., Price, D.L., Cork, L.C., 1988. The neural basis of memory decline in aged monkeys. Neurobiol. Aging 9, 657-666.
230. 3 receptor density elevation in aged Fisher-344 and Brown-Norway (F1) rats. Eur. J. Pharmacol. 308, 283-285.
231. Watanabe, T., Niki, H., 1985. Hippocampal unit activity and delayed response in the monkey. Brain Res. 325, 241-254.
232. Weinberger, D.R., 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660-669.
233. Weinberger, D.R., Berman, K.F., lilowsky, B.P., 1988. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia. Arch. Gen. Psychiatry 45, 609-615.
234. Wenk, G.L., Pierce, D.J., Struble, R.G., Price, D.L., Cork, L.C., 1989. Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol. Aging 10, 11-19.
235. 1 receptors in prefrontal cortex. Nature 376, 572-575.
236. Willner, P., Ahlenius, S., Muscat, R., Scheel-Kruger, J., 1989. The mesolimbic dopamine systems. In: Willner, P., Scheel-Kruger, J., (Eds.), The Mesolimbic Dopamine System, From Motivation to Action. Wiley, New York, pp. 1-15.
237. Wise, R.A., 1987. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35, 227-263.
238. Wise, R.A., 1996. Addictive drugs and brain stimulation reward. Ann. Rev. Neurosci. 19, 319-340.
239. Wise, R.A., Bozarth, M.A., 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
240. Wolkin, A., Jaeger, J., Brodie, J.D., Wolf, A.P., Fowler, J., Rotrosen, J., Gomez-Mont, F., Cancro, R., 1985. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am. J. Psychiatry 142, 564-571.
241. Wood, P.L., Kim, H.S., Marien, M.R., 1987a. Intracerebral dialysis: direct evidence for the utility of 3-Mt measurements as an index of dopamine release. Life Sci. 41, 1-5.
242. Wood, P.L., Kim, H.S., Altar, C.A., 1987b. In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatographymass spectometry measurement of 3-methoxytyramine and normetanephrine. J. Neurochem. 48, 574-579.
243. Yates, C.M., Simpson, J., Gordon, A., Maloney, A.F.J., Allison, Y., Ritchie, I.M., Urquhart, A., 1983. Catecholamines and cholinergic enzymes in the presenile and senile Alzheimer's type dementia and Down's syndrome. Brain Res. 280, 119-126.
244. 2 receptor group, in the rat brain and spinal cord. J. Comp. Neurol. 344, 121-136.
245. Zaleon, C.R., Guthrie, S.K., 1994. Antipsychotic drug use in older adults. Am. J. Hosp. Pharm. 51, 2917-2943.
246. Zelnik, N., Angel, I., Paul, S.M., Kleinmann, J.E., 1986. Decrease density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126, 175-176.
247. Zola-Morgan, S., Squire, L.R., 1986. Memory impairment in monkeys following lesion limited to the hippocampus. Behav. Neurosci. 100, 155-160.
248. Zubenko, G.S., Moossy, J., Martinez, A.J., Rao, G., Claassen, D., Rosen, J., Kopp, U., 1991. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch. Neurol. 48, 619-624.